Hims & Hers Health (NYSE:HIMS) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.12 by 66.67 percent. This is a 300 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $586.01 million which beat the analyst consensus estimate of $538.20 million by 8.88 percent. This is a 110.67 percent increase over sales of $278.17 million the same period last year.